Portal del Investigador
Molecular characterization of carbapenem-producing Pseudomonas aeruginosa isolated from Chilean hospitals
Más información
| Fecha de publicación: | 2020 |
| Objetivos: | 1.To determine the level of resistance to beta-lactams, beta-lactams/beta-lactamase inhibitor, aminoglycosides, polymyxin and fluoroquinolones of carbapenem-resistant strains of P. aeruginosa isolated in Chilean hospitals. 2.To determine the production of ESBL, AmpC, or carbapenemases |
| Año de Inicio/Término: | 2020-2022 |
| Financiamiento/Sponsor: | Pfizer |
| Rol del Usuario: | INVESTIGADOR(A) RESPONSABLE |
| DOI: |
ID#60340625 |
| Notas: | In Chile has increased the isolation of P. aeruginosa in various hospitals, especially in patients at ICUs. These strains have increased their resistance to antibiotics, including carbapenems, which makes it difficult to treat infections in which they are the etiological agent. |